The unique role of cardiovascular magnetic resonance imaging in acute myocarditis

This article addresses the specific diagnostic information provided by cardiovascular magnetic resonance (CMR) in patients with suspected acute myocarditis. It gives an overview of the current evidence of the ability of CMR to detect myocardial inflammation and discusses the added value as well as its limitations in clinical settings. Because of the large variety of symptoms and the limited specificity of other non-invasive procedures, the identification of myocardial inflammation is of paramount importance. Because of its accuracy in imaging ventricular volumes and function and its unique ability to visualize myocardial edema, scar, and other tissue abnormalities, CMR has emerged as the prime non-invasive diagnostic tool in patients with acute myocarditis. The presence of myocardial inflammation is not specific to viral myocarditis or other forms of acute myocardial injury, and the regional distribution within the myocardium helps differentiate acute myocarditis from other diseases. The currently recommended diagnostic criteria (Lake Louise Criteria) include markers for hyperemia/capillary leak, edema, and inflammatory scarring. Their diagnostic accuracy of close to 80% is satisfactory to rule in myocarditis, yet the negative predictive value is less than 70%. Novel CMR techniques, especially T1 and T2 mapping, have been shown to further improve the diagnostic utility.

[1]  R. N. Planken,et al.  Additional diagnostic value of CMR to the European Society of Cardiology (ESC) position statement criteria in a large clinical population of patients with suspected myocarditis , 2018, European heart journal cardiovascular Imaging.

[2]  C. Antoniades,et al.  Diagnostic Accuracy of Cardiovascular Magnetic Resonance in Acute Myocarditis: A Systematic Review and Meta-Analysis. , 2018, JACC. Cardiovascular imaging.

[3]  A. Huber,et al.  Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping , 2018, Journal of Cardiovascular Magnetic Resonance.

[4]  G. Pontone,et al.  Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study. , 2017, Journal of the American College of Cardiology.

[5]  Richard B. Thompson,et al.  Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2017, Journal of Cardiovascular Magnetic Resonance.

[6]  B. Schnackenburg,et al.  A novel multiparametric imaging approach to acute myocarditis using T2-mapping and CMR feature tracking , 2017, Journal of Cardiovascular Magnetic Resonance.

[7]  B. Schnackenburg,et al.  Tissue characterization by T1 and T2 mapping cardiovascular magnetic resonance imaging to monitor myocardial inflammation in healing myocarditis , 2017, European heart journal cardiovascular Imaging.

[8]  Malte Kelm,et al.  Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis , 2017, Journal of Cardiovascular Magnetic Resonance.

[9]  Christopher A. Miller,et al.  Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases , 2017, The International Journal of Cardiovascular Imaging.

[10]  M. Robson,et al.  Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents , 2014, Journal of Cardiovascular Magnetic Resonance.

[11]  G. Schuler,et al.  Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. , 2012, JACC. Cardiovascular imaging.

[12]  K. Klingel,et al.  Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. , 2012, Journal of the American College of Cardiology.

[13]  L. Cooper,et al.  Update on myocarditis. , 2012, Journal of the American College of Cardiology.

[14]  Paaladinesh Thavendiranathan,et al.  Improved Detection of Myocardial Involvement in Acute Inflammatory Cardiomyopathies Using T2 Mapping , 2012, Circulation. Cardiovascular imaging.

[15]  J. Ridgway,et al.  Cardiovascular magnetic resonance physics for clinicians: part II , 2010, Journal of Cardiovascular Magnetic Resonance.

[16]  J. Francis,et al.  The current and emerging role of cardiovascular magnetic resonance in the diagnosis of nonischemic cardiomyopathies. , 2011, Progress in cardiovascular diseases.

[17]  J. Ridgway Cardiovascular magnetic resonance physics for clinicians: part I , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[18]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[19]  M. Friedrich Tissue characterization of acute myocardial infarction and myocarditis by cardiac magnetic resonance. , 2008, JACC. Cardiovascular imaging.

[20]  Renu Virmani,et al.  A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .

[21]  A. Yan,et al.  Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: prospects for detecting myocardial inflammation. , 2005, Journal of the American College of Cardiology.

[22]  F. Hayden,et al.  Cardiac findings during uncomplicated acute influenza in ambulatory adults. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.